BRIEF-Adocia and Lilly teams up to develop ultra-rapid insulin

* Lilly and Adocia announce alliance to co-develop ultra-rapid insulin based on BioChaperone technology
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.